| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/13/2011 | CN101185737B Orally-administered traditional Chinese medicine for treating stomach-heat type hematemesis |
| 04/13/2011 | CN101115709B Aminocarboxylic acid derivative and medicinal use thereof |
| 04/13/2011 | CN101112387B Smectite turbid liquor for treating non-infectious diarrhea and method for preparing the same |
| 04/13/2011 | CN101028343B Total alkaloid of meadowrue corydalis and its purification and medicinal composition |
| 04/13/2011 | CN101028264B Huisanliu tablets as medicine and their preparation |
| 04/12/2011 | US7923559 7-(3-pyridyl)-1,7-diazaspiro[4.4]nonane; mania, anxiety, dyslexia, schizophrenia, depression, obsessive-compulsive disorders, Tourette's syndrome |
| 04/12/2011 | CA2488775C Fcyriia transgenic animal model for autoimmune disease |
| 04/12/2011 | CA2475619C Piperidine derivatives |
| 04/12/2011 | CA2462905C Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 04/12/2011 | CA2458035C Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/12/2011 | CA2387107C Derivatives of dicarboxylic acid having pharmaceutical properties |
| 04/12/2011 | CA2354054C Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 04/07/2011 | WO2011041369A1 Salts, solvates, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same |
| 04/07/2011 | WO2011041300A1 Reduced-odor polyol composition and method of producing same |
| 04/07/2011 | WO2011040535A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | WO2011040220A1 Composition for treatment of pancreatic cancer |
| 04/07/2011 | WO2011039328A1 Administration of bifidobacterium breve during infancy to prevent inflammation later in life |
| 04/07/2011 | WO2011038754A1 Oral care compositions containing human recombinant interleukin-1 |
| 04/07/2011 | WO2011038662A1 Compounds as trpv1 blockers, pharmaceutical compositions and medical uses thereof |
| 04/07/2011 | WO2011019641A3 Nutritional compositions including exogenous nucleotides |
| 04/07/2011 | WO2010096564A3 Dietary supplements containing polyunsaturated omega-3 fatty acids and probiotic bacteria with potential gastrointestinal and dermatological benefits |
| 04/07/2011 | WO2010090723A3 Methods of inhibiting fibrogenesis and treating fibrotic disease |
| 04/07/2011 | US20110082407 Combination Therapies for the Treatment of Obesity |
| 04/07/2011 | US20110082209 Novel Salts of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid |
| 04/07/2011 | US20110082206 Heteroatom containing substituted fatty acids |
| 04/07/2011 | US20110082202 Fatty acid acifran derivatives and their uses |
| 04/07/2011 | US20110082188 Gene expression profiling of inflammatory bowel disease |
| 04/07/2011 | US20110082181 Compounds as Lysophosphatidic Acid Receptor Antagonists |
| 04/07/2011 | US20110082174 Solid state forms of racemic ilaprazole |
| 04/07/2011 | US20110082173 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 04/07/2011 | US20110082164 Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| 04/07/2011 | US20110082151 Sulfonylurea modulators of endothelin receptor |
| 04/07/2011 | US20110082149 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation |
| 04/07/2011 | US20110082142 Selective kinase inhibitors |
| 04/07/2011 | US20110082139 Substituted 8-[6-amino-3-pyridyl]xanthines |
| 04/07/2011 | US20110082119 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 04/07/2011 | US20110082103 Anoectochilus SPP. polysaccharide extracts for stimulating growth of advantageous bacteria, stimuating release of granulocyte colony-Stimulating factor, modulating T helper cell type I, and/or modulating T helper cell type II and uses of the same |
| 04/07/2011 | US20110082079 Glucagon-like peptide-1 derivatives and their pharmaceutical use |
| 04/07/2011 | US20110081426 Aminothiazole modulators of beta-3-adrenoreceptor |
| 04/07/2011 | US20110081424 Nutritional composition for bariatric surgery patients |
| 04/07/2011 | US20110081412 Orally disintegrable tablets |
| 04/07/2011 | US20110081366 Immunostimulatory nucleic acid molecules |
| 04/07/2011 | US20110081361 Antibodies that bind interleukin-4 receptor |
| 04/07/2011 | US20110081340 Methods for treating disease using an anti-il-21 receptor antibody |
| 04/07/2011 | US20110081339 Methods of using il-17 receptor a antibodies |
| 04/07/2011 | US20110081337 Function of gpr4 in vascular inflammatory response to acidosis and related methods |
| 04/07/2011 | US20110081332 Treatment of non-alcoholic steatotic hepatitis (nash) |
| 04/07/2011 | US20110081323 Methods and compositions for organ and tissue functionality |
| 04/07/2011 | US20110081321 Omentum as a source of stromal/stem cells and medical treatments using stromal/stem cells |
| 04/07/2011 | US20110081320 Treatment/Cure of Autoimmune Disease |
| 04/07/2011 | US20110081319 Composition and use of phyto-percolate for treatment of disease |
| 04/07/2011 | DE102009042459A1 Composition, useful for the treatment and prophylaxis of diseases of the liver, cardiovascular disease, dementia and Alzheimer's disease, comprises colloidal silver, gold and/or platinum and a choline-containing phosphoglyceride |
| 04/07/2011 | CA2776195A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | CA2776141A1 Reduced-odor polyol composition and method of producing same |
| 04/07/2011 | CA2775925A1 Salts, solvates and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305684A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 04/06/2011 | EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor |
| 04/06/2011 | EP2305663A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2305306A1 Neuroinvasion inhibitor |
| 04/06/2011 | EP2305305A1 Agent for induction/maintenance of remission |
| 04/06/2011 | EP2305291A1 Use of proteasome inhibitors for the treatment of HIV infections |
| 04/06/2011 | EP2305287A1 Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection |
| 04/06/2011 | EP2305276A2 Processed lipoaspirate cells for use in therapy |
| 04/06/2011 | EP2305259A1 Novel substituted benzimidazole dosage forms and method of using same |
| 04/06/2011 | EP2305254A1 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists for the treatment of gatrointestinal conditions |
| 04/06/2011 | EP2305248A1 Substituted phenethylsulfones and method of reducing tnf-alpha levels |
| 04/06/2011 | EP2305245A1 Treatment of diseases associated with the use of antibiotics |
| 04/06/2011 | EP2305244A1 Treatment of diseases associated with the use of antibiotics |
| 04/06/2011 | EP2305241A1 Use of a 5'-nucleotide for preventing/improving functional digestive disorder |
| 04/06/2011 | EP2305240A1 Nutrient composition and composition for prevention/mitigation of digestive tract depression |
| 04/06/2011 | EP2305234A1 Pharmaceutical composition for treatment or prevention of hbv infection |
| 04/06/2011 | EP2305220A2 Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| 04/06/2011 | EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 04/06/2011 | EP2303868A2 Stable r(+)-lansoprazole amine salt and a process for preparing the same |
| 04/06/2011 | EP2303860A2 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors |
| 04/06/2011 | EP2303294A1 Probiotics to improve gut microbiota |
| 04/06/2011 | EP2303289A1 Mono ( iron hydroxypyrone ) and combination ( iron hydroxypyrone and gi inflammation inhibiting agents ) compositions for anaemia or h. pylori infections |
| 04/06/2011 | EP2303262A1 Dpp-iv inhibitors for use in the treatment of nafld |
| 04/06/2011 | EP2303261A1 Use of cyclolignans for the treatment of a hyperactive immune system |
| 04/06/2011 | EP1919865B1 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 04/06/2011 | EP1796696B1 Compounds, compositions, formulations and process for preparation thereof and method of treatment and management of acidity and related disorders |
| 04/06/2011 | EP1602660B1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators |
| 04/06/2011 | EP1519939B9 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 04/06/2011 | EP1404324B2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/06/2011 | CN201782981U 一种提高微生态制剂与相关活性成份安定性及效用的结构 Probiotics with a way to improve the stability and effectiveness of the active ingredient associated structures |
| 04/06/2011 | CN201782427U Novel healthcare pillow |
| 04/06/2011 | CN1840177B Injection liquid of thymic peptide alpha 1 and preparation method thereof |
| 04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
| 04/06/2011 | CN102007133A 3-phenylpyrazolo[5,1-b]thiazole compounds |
| 04/06/2011 | CN102006877A Oral dosage composition |
| 04/06/2011 | CN102006874A Silicia for the inhinition of a protease |
| 04/06/2011 | CN102002493A Application of small RNA-326 in preparation of medicament |
| 04/06/2011 | CN102002077A Novel conjugate of sialic acid-zinc methionine, preparation process and application thereof |
| 04/06/2011 | CN102000346A Nanometer nucleic acid guide medicine, and preparation method and application thereof |